首页> 外文会议>Water quality technology conference >PHARMACEUTICAL COMPOUNDS: OCCURRENCE IN THE ENVIRONMENT AND FATE IN DRINKING WATER TREATMENT
【24h】

PHARMACEUTICAL COMPOUNDS: OCCURRENCE IN THE ENVIRONMENT AND FATE IN DRINKING WATER TREATMENT

机译:药物化合物:饮用水处理中环境和命运的发生

获取原文

摘要

The limited quantity of unpolluted water as a resource for drinking water production is one of the majorchallenges in the future around the world. Shortly after the concern about endocrine disrupters hasarisen in the water community, pharmaceutical compounds have also recently become a question ofinterest and subject of study. Actually, bioactive ingredients of pharmaceuticals are excreted by theusers (animal or human) as partly metabolized. During wastewater treatment, these metabolites and theunaltered parent compounds will undergo further transformations. However, the literature shows thatmany such compounds are not biodegradable; they are discharged into the environment where theymay survive. In contrast to what happens with pesticides, they will be mostly released in highlypopulated areas, continuously rather than at definite seasons of the year. Therefore they represent apotential pollution in resources used for drinking water production. Because of the complexity andvariety of bioactive substances, existing data are still limited and much remains unknown about theirpotential toxic effect in the environment, their occurrence in resources, and their treatability in drinkingwater production. The widest literature to date deals with antibiotics, which are suspected to induce aresistance of the bacteria which would make them pathogenic for the humans.In order to investigate some of those questions, Ondeo Services has begun a European Project namedPOSEIDON (Assessment of Technologies for the Removal of Pharmaceuticals and Personal CareProducts in Sewage and Drinking Water Facilities to Improve the Indirect Potable Water Reuse), incollaboration with several universities around Europe. It is supported by the European Community,over 2001-2003.The major pharmaceuticals consumed in France have been identified and will be presented. Analyticalcampaigns have confirmed the presence of some of those compounds in wastewater treatment planteffluents and in the Seine River. Among them are iodinated contrast media, betablockers, acidcompounds such as ibuprofen or bezafibrate. Treatability data of some of those compounds will also bepresented.
机译:有限的无污染水作为饮用水的生产资源是主要因素之一 世界各地未来的挑战。对内分泌干扰物的关注不久之后 在水社区中出现的药物化合物最近也成为了一个问题 兴趣和研究主题。实际上,药物的生物活性成分是通过 使用者(动物或人类)被部分代谢。在废水处理过程中,这些代谢产物和 未改变的母体化合物将进行进一步的转化。但是,文献表明 许多此类化合物不可生物降解;它们被排放到他们所处的环境中 可能生存。与杀虫剂发生的情况相反,它们将以高浓度释放 人口稠密的地区,而不是每年的特定季节。因此,它们代表了 饮用水生产资源的潜在污染。由于复杂和 生物活性物质种类繁多,现有数据仍然有限,对其活性仍然知之甚少 在环境中的潜在毒性作用,其在资源中的存在及其在饮用中的可治疗性 产水。迄今为止,最广泛的文献涉及抗生素,它们被怀疑会诱发细菌感染。 细菌的抗药性,这将使它们对人类致病。 为了调查其中的一些问题,Ondeo Services已启动了一个名为“欧洲项目”的项目 POSEIDON(去除药物和个人护理的技术评估 污水和饮用水设施中的产品,以改善间接饮用水的再利用), 与欧洲各地的几所大学合作。它得到了欧洲共同体的支持, 在2001-2003年之间。 已经确定了法国将消耗的主要药品,并将进行介绍。分析型 运动已经证实废水处理厂中有些化合物的存在 废水和塞纳河。其中包括碘化造影剂,β受体阻滞剂,酸 化合物,如布洛芬或苯扎贝特。其中一些化合物的可处理性数据也将是 提出了。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号